• TMCB(CK2 and ERK8 Inhibitor): Illuminating Protein Conden...

  2025-09-30

  Explore how TMCB(CK2 and ERK8 inhibitor), a tetrabromo benzimidazole derivative, is redefining the frontiers of protein interaction and phase separation research. This thought-leadership article bridges mechanistic insights with strategic guidance, equipping translational researchers with actionable intelligence to harness next-generation chemical probes for dissecting condensate biology, enzyme regulation, and antiviral strategies.

• Paclitaxel (Taxol): Next-Generation Tools for Microtubule...

  2025-09-29

  Explore the advanced scientific applications of Paclitaxel (Taxol) as a microtubule polymer stabilizer in cancer research and neurotoxicity modeling. This article uniquely integrates cutting-edge mRNA-based neuroprotection and anti-angiogenic strategies, providing fresh insights for researchers.

• Phenylmethanesulfonyl Fluoride (PMSF): Unraveling Irrever...

  2025-09-28

  Explore the advanced role of phenylmethanesulfonyl fluoride (PMSF) as an irreversible serine protease inhibitor in protein extraction and cell signaling research. This article uniquely examines PMSF’s mechanistic impact on protease regulation in inflammation and COVID-19 models, providing deeper scientific insights.

• BGJ398 (NVP-BGJ398): Precision FGFR1/2/3 Inhibition for O...

  2025-09-27

  Explore the unique capabilities of BGJ398, a selective FGFR inhibitor, in dissecting FGFR-driven malignancies and apoptosis pathways. This article offers an advanced analysis of BGJ398’s mechanistic value and its application in translational oncology research.

• Torin2 in Apoptosis Research: Beyond mTOR Inhibition in C...

  2025-09-26

  Explore how Torin2, a selective mTOR inhibitor, uniquely enables apoptosis research by dissecting active death signaling beyond transcriptional loss. Discover advanced insights into protein kinase inhibition and mTOR pathway modulation for innovative cancer research.

• DMH1 in Action: Selective BMP Signaling Inhibition for Hi...

  2025-09-25

  Explore how DMH1, a selective BMP type I receptor inhibitor, is advancing precision control of cellular fate in organoid systems and non-small cell lung cancer research. This article uniquely details mechanistic insights, emerging applications, and experimental optimization strategies for DMH1.

• Sulfo-NHS-SS-Biotin: Transforming Cell Surface Proteomics

  2025-09-24

  Discover how Sulfo-NHS-SS-Biotin, a leading amine-reactive biotinylation reagent, enables unparalleled specificity and reversibility in cell surface protein labeling. This in-depth guide explores its unique mechanistic advantages, advanced applications, and integration with modern proteostasis research.

• Protease Inhibitor Cocktail EDTA-Free: Enhancing Protein ...

  2025-09-23

  Explore how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) safeguards protein complexes during extraction, with an emphasis on its role in phosphorylation-sensitive and plant-based protocols. Learn why its EDTA-free formulation is pivotal for advanced proteomics and kinase assays.

• ABT-199 (Venetoclax): Probing Apoptotic Pathways in AML a...

  2025-09-22

  This article examines the scientific utility of ABT-199 (Venetoclax), a highly selective Bcl-2 inhibitor, for dissecting mitochondrial apoptosis in hematologic malignancies. Emphasis is placed on recent mechanistic insights into apoptosis signaling, with practical guidance for apoptosis assay design and translational research.

• Protease Inhibitor Cocktail EDTA-Free: Advanced Strategie...

  2025-09-19

  Explore the scientific impact of the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) on protein extraction, with a focus on preserving protein integrity in phosphorylation and signaling analyses. This article reviews advanced inhibitor selection and application strategies for rigorous proteomics research.

• Enhancing mRNA Stability: HyperScribe™ Poly (A) Tailing K...

  2025-09-18

  Explore how the HyperScribe™ Poly (A) Tailing Kit streamlines polyadenylation of RNA transcripts, enabling improved mRNA stability and translation efficiency for advanced in vitro research applications.

• br Acknowledgments This work was supported by Grant in aid

  2025-03-03

  

  Acknowledgments This work was supported by Grant-in-aid for Scientific Research (S) (20229008) (to T.K.), Targeted Proteins Research Program (to T.K.), the Global COE Research Program (to T.K.) and Translational Systems Biology and Medicine Initiative (to T.K.) from the Ministry of Education, Cul

• The present study showed for the first time

  2025-03-03

  

  The present study showed, for the first time, that hirsutine, hirsuteine, rhynchophylline, isorhynchophylline, corynoxeine, and isocorynoxeine in yokukansan can inhibit the 5-HT3 receptor current. These data indicate that part of the effect of yokukansan against the behavioral and psychological symp

• Numerous studies have shown that PUFA incorporation

  2025-03-03

  

  Numerous studies have shown that ω-3 PUFA incorporation into the lipid raft can affect the distribution and function of protein in the lipid raft by altering raft composition [25], [26], [27]. For example, DHA treatment excluded phospholipase D (PLD) from lipid raft toward non-lipid raft, resulting

• br Results br Discussion Today enzymes play important roles

  2025-03-03

  

  Results Discussion Today, enzymes play important roles in various fields. A good assay for enzyme activity is of great value, especially when it has good specificity, sensitivity, reproducibility and economy. ADK is the first identified enzyme in the metabolic pathway of adenosine salvage [15,

15560 records 1/1038 page Next 12345 下5页 Last page